Detailed information for compound 2173083

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 251.167 | Formula: C18H21N
  • H donors: 0 H acceptors: 1 LogP: 5.04 Rotable bonds: 1
    Rule of 5 violations (Lipinski): 1
  • SMILES: Cc1cc(C)c2c(c1)nc(c(c2)C1=CCCCC1)C
  • InChi: InChI=1S/C18H21N/c1-12-9-13(2)16-11-17(14(3)19-18(16)10-12)15-7-5-4-6-8-15/h7,9-11H,4-6,8H2,1-3H3
  • InChiKey: WKEPDBATSXCFTN-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens proteasome (prosome, macropain) subunit, beta type, 1 References
Homo sapiens proteasome (prosome, macropain) subunit, beta type, 5 References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Mycobacterium leprae proteasome (beta subunit) PrcB Get druggable targets OG5_127100 All targets in OG5_127100
Giardia lamblia Proteasome subunit beta type 5 precursor Get druggable targets OG5_127100 All targets in OG5_127100
Trypanosoma brucei proteasome beta 6 subunit Get druggable targets OG5_127834 All targets in OG5_127834
Schistosoma mansoni proteasome subunit beta 1 (T01 family) Get druggable targets OG5_127834 All targets in OG5_127834
Leishmania major proteasome beta 6 subunit, putative,20S proteasome beta 6 subunit, putative Get druggable targets OG5_127834 All targets in OG5_127834
Cryptosporidium hominis proteasome subunit beta type 1 (20S proteasome alpha subunit F) (20S proteasome subunit beta-6) Get druggable targets OG5_127834 All targets in OG5_127834
Leishmania infantum proteasome beta 6 subunit, putative,20S proteasome beta 6 subunit, putative Get druggable targets OG5_127834 All targets in OG5_127834
Theileria parva proteasome subunit beta type 5, putative Get druggable targets OG5_127100 All targets in OG5_127100
Cryptosporidium parvum Pre2p/proteasome subunit beta type 5; NTN hydrolase fold Get druggable targets OG5_127100 All targets in OG5_127100
Trypanosoma brucei gambiense proteasome beta 6 subunit,20S proteasome beta 6 subunit, putative Get druggable targets OG5_127834 All targets in OG5_127834
Cryptosporidium parvum proteasome subunit beta type 1, putative Get druggable targets OG5_127834 All targets in OG5_127834
Leishmania major proteasome beta 5 subunit, putative Get druggable targets OG5_127100 All targets in OG5_127100
Leishmania mexicana proteasome beta 6 subunit, putative,20S proteasome beta 6 subunit, putative Get druggable targets OG5_127834 All targets in OG5_127834
Leishmania donovani proteasome beta 6 subunit, putative Get druggable targets OG5_127834 All targets in OG5_127834
Leishmania mexicana proteasome beta 5 subunit, putative Get druggable targets OG5_127100 All targets in OG5_127100
Plasmodium yoelii proteasome subunit beta type 1-related Get druggable targets OG5_127834 All targets in OG5_127834
Entamoeba histolytica proteasome subunit beta type 1, putative Get druggable targets OG5_127834 All targets in OG5_127834
Plasmodium knowlesi proteasome subunit beta type-5, putative Get druggable targets OG5_127100 All targets in OG5_127100
Candida albicans proteasome subunit Get druggable targets OG5_127834 All targets in OG5_127834
Schistosoma japonicum ko:K02732 20S proteasome subunit beta 6, putative Get druggable targets OG5_127834 All targets in OG5_127834
Trypanosoma congolense proteasome subunit beta type-5, putative Get druggable targets OG5_127100 All targets in OG5_127100
Mycobacterium tuberculosis Proteasome beta subunit PrcB; assembles with alpha subunit PrcA. Get druggable targets OG5_127100 All targets in OG5_127100
Echinococcus multilocularis proteasome (prosome, macropain) subunit, beta Get druggable targets OG5_127834 All targets in OG5_127834
Babesia bovis proteasome epsilon subunit, putative Get druggable targets OG5_127100 All targets in OG5_127100
Schistosoma mansoni proteasome catalytic subunit 3 (T01 family) Get druggable targets OG5_127100 All targets in OG5_127100
Schistosoma japonicum ko:K02737 20S proteasome subunit beta 5, putative Get druggable targets OG5_127100 All targets in OG5_127100
Plasmodium yoelii proteosome PSMB5/8 protein Get druggable targets OG5_127100 All targets in OG5_127100
Trypanosoma congolense proteasome beta 6 subunit Get druggable targets OG5_127834 All targets in OG5_127834
Toxoplasma gondii proteasome subunit beta type 1, putative Get druggable targets OG5_127834 All targets in OG5_127834
Mycobacterium ulcerans proteasome PrcB Get druggable targets OG5_127100 All targets in OG5_127100
Giardia lamblia Proteasome subunit beta type 1 Get druggable targets OG5_127834 All targets in OG5_127834
Brugia malayi Proteasome A-type and B-type family protein Get druggable targets OG5_127100 All targets in OG5_127100
Trypanosoma cruzi proteasome subunit beta type-5, putative Get druggable targets OG5_127100 All targets in OG5_127100
Candida albicans proteasome subunit Get druggable targets OG5_127100 All targets in OG5_127100
Theileria parva proteasome beat subunit, putative Get druggable targets OG5_127834 All targets in OG5_127834
Leishmania donovani proteasome subunit beta type-5, putative Get druggable targets OG5_127100 All targets in OG5_127100
Brugia malayi proteasome subunit beta type 1 Get druggable targets OG5_127834 All targets in OG5_127834
Echinococcus granulosus proteasome prosome macropain subunit beta Get druggable targets OG5_127834 All targets in OG5_127834
Plasmodium vivax proteasome subunit beta type-5, putative Get druggable targets OG5_127100 All targets in OG5_127100
Trypanosoma brucei proteasome subunit beta type-5, putative Get druggable targets OG5_127100 All targets in OG5_127100
Leishmania infantum proteasome beta 5 subunit, putative Get druggable targets OG5_127100 All targets in OG5_127100
Trypanosoma cruzi proteasome beta 6 subunit, putative Get druggable targets OG5_127834 All targets in OG5_127834
Entamoeba histolytica proteasome subunit beta type 5 precursor, putative Get druggable targets OG5_127100 All targets in OG5_127100
Neospora caninum Family T1, proteasome beta subunit, threonine peptidase, related Get druggable targets OG5_127100 All targets in OG5_127100
Trichomonas vaginalis Family T1, proteasome beta subunit, threonine peptidase Get druggable targets OG5_127100 All targets in OG5_127100
Babesia bovis proteasome A-type and B-type family protein Get druggable targets OG5_127834 All targets in OG5_127834
Trypanosoma cruzi proteasome subunit beta type-5, putative Get druggable targets OG5_127100 All targets in OG5_127100
Plasmodium berghei proteasome subunit beta type-1, putative Get druggable targets OG5_127834 All targets in OG5_127834
Plasmodium knowlesi proteasome subunit beta type-1, putative Get druggable targets OG5_127834 All targets in OG5_127834
Trypanosoma brucei gambiense proteasome beta 5 subunit, putative Get druggable targets OG5_127100 All targets in OG5_127100
Cryptosporidium hominis hypothetical protein Get druggable targets OG5_127100 All targets in OG5_127100
Leishmania braziliensis proteasome beta 5 subunit, putative Get druggable targets OG5_127100 All targets in OG5_127100
Trichomonas vaginalis Family T1, proteasome beta subunit, threonine peptidase Get druggable targets OG5_127834 All targets in OG5_127834
Echinococcus granulosus proteasome prosome macropain Get druggable targets OG5_127100 All targets in OG5_127100
Loa Loa (eye worm) proteasome subunit beta type 1 Get druggable targets OG5_127834 All targets in OG5_127834
Candida albicans proteasome subunit Get druggable targets OG5_127100 All targets in OG5_127100
Loa Loa (eye worm) proteasome A-type and B-type family protein Get druggable targets OG5_127100 All targets in OG5_127100
Toxoplasma gondii proteasome subunit beta type, putative Get druggable targets OG5_127100 All targets in OG5_127100
Candida albicans proteasome subunit Get druggable targets OG5_127834 All targets in OG5_127834
Echinococcus multilocularis proteasome (prosome, macropain) Get druggable targets OG5_127100 All targets in OG5_127100
Plasmodium vivax proteasome subunit beta type-1, putative Get druggable targets OG5_127834 All targets in OG5_127834
Neospora caninum hypothetical protein Get druggable targets OG5_127834 All targets in OG5_127834
Plasmodium berghei proteasome subunit beta type-5, putative Get druggable targets OG5_127100 All targets in OG5_127100
Leishmania braziliensis proteasome beta 6 subunit, putative,20S proteasome beta 6 subunit, putative Get druggable targets OG5_127834 All targets in OG5_127834
Plasmodium falciparum proteasome subunit beta type-5 Get druggable targets OG5_127100 All targets in OG5_127100
Trypanosoma cruzi proteasome beta 6 subunit, putative Get druggable targets OG5_127834 All targets in OG5_127834
Plasmodium falciparum proteasome subunit beta type-1, putative Get druggable targets OG5_127834 All targets in OG5_127834
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Plasmodium falciparum proteasome subunit beta type-5 proteasome (prosome, macropain) subunit, beta type, 1 241 aa 194 aa 27.3 %
Plasmodium falciparum proteasome subunit alpha type-5, putative proteasome (prosome, macropain) subunit, beta type, 5 160 aa 148 aa 23.0 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Plasmodium vivax proteasome subunit beta type-5, putative 0.0093 1 1
Plasmodium falciparum proteasome subunit beta type-5 0.0093 1 1
Toxoplasma gondii proteasome subunit beta type, putative 0.0093 1 1
Mycobacterium leprae proteasome (beta subunit) PrcB 0.0093 1 0.5
Trypanosoma brucei proteasome subunit beta type-5, putative 0.0093 1 1
Giardia lamblia Proteasome subunit beta type 5 precursor 0.0093 1 1
Mycobacterium tuberculosis Proteasome beta subunit PrcB; assembles with alpha subunit PrcA. 0.0093 1 0.5
Loa Loa (eye worm) proteasome A-type and B-type family protein 0.0093 1 1
Leishmania major proteasome beta 5 subunit, putative 0.0093 1 1
Echinococcus granulosus proteasome prosome macropain 0.0093 1 1
Trypanosoma cruzi proteasome subunit beta type-5, putative 0.0093 1 1
Trichomonas vaginalis Family T1, proteasome beta subunit, threonine peptidase 0.0093 1 1
Trypanosoma cruzi proteasome subunit beta type-5, putative 0.0093 1 1
Echinococcus multilocularis proteasome (prosome, macropain) 0.0093 1 1
Mycobacterium ulcerans proteasome PrcB 0.0093 1 0.5
Schistosoma mansoni proteasome catalytic subunit 3 (T01 family) 0.0093 1 1
Entamoeba histolytica proteasome subunit beta type 5 precursor, putative 0.0093 1 1

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 14.4 uM Inhibition of human 20S proteasome chymotryptic-like activity using Suc-LLVY-AMC as substrate measured for 30 mins by fluorescence assay ChEMBL. 27112450
IC50 (binding) = 17.7 uM Inhibition of human 20S proteasome caspase beta1-like activity using Z-LLE-AMC as substrate measured for 30 mins by fluorescence assay ChEMBL. 27112450
IC50 (binding) > 25 uM Inhibition of human 20S proteasome tryptic beta2-like activity using Z-ARR-AMC as substrate measured for 30 mins by fluorescence assay ChEMBL. 27112450
Km (binding) = 13.95 mol/L Mixed type inhibition of human 20S proteasome chymotryptic-like activity using Suc-LLVY-AMC as substrate assessed as Km for substrate at 4 uM by Lineweaver-Burk plot analysis (Rvb = 4.633 to 16.63 umol) ChEMBL. 27112450
Km (binding) = 14.8 mol/L Mixed type inhibition of human 20S proteasome chymotryptic-like activity using Suc-LLVY-AMC as substrate assessed as Km for substrate at 10 uM by Lineweaver-Burk plot analysis (Rvb = 4.633 to 16.63 umol) ChEMBL. 27112450
Km (binding) = 18.08 mol/L Mixed type inhibition of human 20S proteasome chymotryptic-like activity using Suc-LLVY-AMC as substrate assessed as Km for substrate at 6 uM by Lineweaver-Burk plot analysis (Rvb = 4.633 to 16.63 umol) ChEMBL. 27112450
Km (binding) = 22.35 mol/L Mixed type inhibition of human 20S proteasome chymotryptic-like activity using Suc-LLVY-AMC as substrate assessed as Km for substrate at 5 uM by Lineweaver-Burk plot analysis (Rvb = 4.633 to 16.63 umol) ChEMBL. 27112450
Km (binding) = 31.2 mol/L Mixed type inhibition of human 20S proteasome chymotryptic-like activity using Suc-LLVY-AMC as substrate assessed as Km for substrate at 9 uM by Lineweaver-Burk plot analysis (Rvb = 4.633 to 16.63 umol) ChEMBL. 27112450
Km (binding) = 31.72 mol/L Mixed type inhibition of human 20S proteasome chymotryptic-like activity using Suc-LLVY-AMC as substrate assessed as Km for substrate at 7 uM by Lineweaver-Burk plot analysis (Rvb = 4.633 to 16.63 umol) ChEMBL. 27112450
Km (binding) = 32.61 mol/L Mixed type inhibition of human 20S proteasome chymotryptic-like activity using Suc-LLVY-AMC as substrate assessed as Km for substrate at 8 uM by Lineweaver-Burk plot analysis (Rvb = 4.633 to 16.63 umol) ChEMBL. 27112450
Vmax (binding) = 0.03289 micromol/min Mixed type inhibition of human 20S proteasome chymotryptic-like activity using Suc-LLVY-AMC as substrate assessed as Vmax for substrate at 10 uM by Lineweaver-Burk plot analysis (Rvb = 0.1959 to 0.2691 umol/min ) ChEMBL. 27112450
Vmax (binding) = 0.04663 micromol/min Mixed type inhibition of human 20S proteasome chymotryptic-like activity using Suc-LLVY-AMC as substrate assessed as Vmax for substrate at 9 uM by Lineweaver-Burk plot analysis (Rvb = 0.1959 to 0.2691 umol/min) ChEMBL. 27112450
Vmax (binding) = 0.05875 micromol/min Mixed type inhibition of human 20S proteasome chymotryptic-like activity using Suc-LLVY-AMC as substrate assessed as Vmax for substrate at 8 uM by Lineweaver-Burk plot analysis (Rvb = 0.1959 to 0.2691 umol/min) ChEMBL. 27112450
Vmax (binding) = 0.06738 micromol/min Mixed type inhibition of human 20S proteasome chymotryptic-like activity using Suc-LLVY-AMC as substrate assessed as Vmax for substrate at 7 uM by Lineweaver-Burk plot analysis (Rvb = 0.1959 to 0.2691 umol/min) ChEMBL. 27112450
Vmax (binding) = 0.07026 micromol/min Mixed type inhibition of human 20S proteasome chymotryptic-like activity using Suc-LLVY-AMC as substrate assessed as Vmax for substrate at 6 uM by Lineweaver-Burk plot analysis (Rvb = 0.1959 to 0.2691 umol/min) ChEMBL. 27112450
Vmax (binding) = 0.09235 micromol/min Mixed type inhibition of human 20S proteasome chymotryptic-like activity using Suc-LLVY-AMC as substrate assessed as Vmax for substrate at 5 uM by Lineweaver-Burk plot analysis (Rvb = 0.1959 to 0.2691 umol/min) ChEMBL. 27112450
Vmax (binding) = 0.0959 micromol/min Mixed type inhibition of human 20S proteasome chymotryptic-like activity using Suc-LLVY-AMC as substrate assessed as Vmax for substrate at 4 uM by Lineweaver-Burk plot analysis (Rvb = 0.1959 to 0.2691 umol/min) ChEMBL. 27112450

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.